Skip to main content

Table 1 Example of anti-cancer drugs phase I/II completed studies

From: “Right-to-Try” experimental drugs: an overview

Disease or conditionsInterventions
Colorectal cancerDrug: Capecitabine and Aflibercept
Metastatic breast cancerDrug: Tivozanib (AV-951) + paclitaxel
Bladder cancerBiological: Vesigenurtaclel-1 (HS-410)
Biological: Placebo
Biological: BCG
Ovarian cancer
Primary peritoneal
Drug: Pemetrexed—Phase 1
Drug: Carboplatin—Phase 1
Drug: Pemetrexed—Phase 2
Drug: Carboplatin—Phase 2
Non-small cell lung cancerDrug: Pazopanib
Drug: Paclitaxel
Non small lung cancerDrug: Pemetrexed
Drug: Cisplatin
Drug: Rabusertib (LY2603618)
Pancreatic cancerDrug: Vantictumab (OMP-18RS)
Drug: Nab-paclitaxel
Drug: Gemcitabine